RIV Capital (TSX: RIV) (OTC: CNPOF), an investment and acquisition company specializing in cannabis, announced that through its sale and investment solicitation process, PharmHouse Inc. completed the sale of its greenhouse facility. The transaction was based on its asset purchase agreement with a company related to Sensei Ag Holdings Inc. PharmHouse noted that it plans to use the proceeds from the sale to reduce its debt. Following the closing of the PharmHouse sale, RIV Capital made a cash payment of an estimated $7.5 million to lenders. The announcement noted that any remaining cash left after fulfillment of the debt obligation will distributed to RIV Capital. “Over the past few quarters, we have worked tirelessly to mitigate our liability exposure on PharmHouse, ensure that our liability does not exceed our disclosed estimates and secure a buyer for the facility,” said RIV Capital president and CEO Narbe Alexandrian in the press release. “With this chapter behind us, our complete focus is on executing on our investment strategy in the U.S. market.”
To view the full press release, visit https://ibn.fm/r7jCU
About RIV Capital
RIV Capital is an investment and acquisition company specializing in cannabis with a portfolio of 13 companies across various segments of the cannabis value chain. The company believes that bringing together people, capital and ideas raises the potential of the entire cannabis industry. By leveraging its industry insights, in-house expertise and thesis-driven approach to investing, RIV Capital aims to provide shareholders with exposure to specialized and disruptive cannabis companies. For more information about the company, please visit www.RIVCapital.com.
NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://ibn.fm/CNPOF
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
